FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia

Conditions

• Acute Myeloid Leukemia

Interventions

• DRUG: Autologous HLA-A*02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells
• DRUG: Azacitidine
• PROCEDURE: Biospecimen Collection
• PROCEDURE: Bone Marrow Aspiration
• PROCEDURE: Bone Marrow Biopsy
• PROCEDURE: Chest Radiography
• PROCEDURE: Computed Tomography
• PROCEDURE: Echocardiography Test
• PROCEDURE: Lumbar Puncture
• PROCEDURE: Multigated Acquisition Scan
• PROCEDURE: Positron Emission Tomography

Sponsor

Fred Hutchinson Cancer Center

Collaborators

• [object Object]